About the Authors
- Indranil Mukhopadhyay
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Abhay Kulkarni
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Sarika Aranake
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Pallavi Karnik
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Mahesh Shetty
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Sandeep Thorat
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Indraneel Ghosh
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Dinesh Wale
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Vikram Bhosale
-
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
- Neelima Khairatkar-Joshi
-
* E-mail: neelima_joshi@glenmarkpharma.com
Affiliation Biological Research, Glenmark Research Centre, Glenmark Pharmaceuticals Ltd., Navi Mumbai, Maharashtra, India
Competing Interests
All the authors are employees of Glenmark Pharmaceuticals Ltd. IM has one patent issued (Thienopyrimidinedione derivatives as trpa1 modulators; Patent No. US8507503), AK has one patent filed (Application No. 3067/MUM/2013) and NKJ has one patent issued (Thienopyrimidinedione derivatives as trpa1 modulators; Patent No. US8507503) and one filed (Application No. 3067/MUM/2013), which is broadly relevant to the work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. However, the authors will not be able to disclose the structure and/or share compound GRC 17536, which is currently under clinical development but will be happy to spare other compounds as mentioned above.
Author Contributions
Conceived and designed the experiments: IM AK NKJ. Performed the experiments: SA PK MS ST IG DW VB. Analyzed the data: IM AK SA PK MS ST IG DW VB. Wrote the paper: IM AK NKJ.